Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-29

Clinical Trial Update: Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

View source ↗

Summary

A clinical trial from the University of Milano Bicocca is evaluating a dual anti-glutamate therapy for super-refractory status epilepticus following cardiac arr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dual anti-glutamate therapy

Snippet

Sponsor: University of Milano Bicocca | Conditions: Status Epilepticus, Cardiac Arrest | Status: RECRUITING